Diagnostic and therapeutic agents for rheumatoid arthritis
OwnerYoshimi Homma, Koichiro Satoinventors
Life of this patent
Estimating the term…
Abstract
The present invention provides a therapeutic agent for rheumatoid arthritis which inhibits the growth of synoviocytes mediated by c-erbB-2 by clarifying the participation of c-erbB-2 in the growth of synoviocytes in rheumatoid arthritis patients and inhibiting the activation or expression of c-erbB-2.
Claims27
A therapeutic agent for rheumatoid arthritis comprising, as an active ingredient, a substance which inhibits the biological activities of c-erbB-2.
A synoviocyte growth inhibitor comprising, as an active ingredient, a substance which inhibits the biological activities of c-erbB-2.
A diagnostic agent for rheumatoid arthritis comprising, as an active ingredient, a substance which specifically binds to c-erbB-2 or to an mRNA or cDNA for c-erbB-2.
Dependencies are inferred from the claim text.